Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Lycopus Virginicus Whole is a non-standardized plant allergenic extract used primarily in diagnostic and therapeutic applications for hypersensitivity. It belongs to the class of botanical extracts and is utilized in clinical allergy testing and specific immunotherapy.
Name
Lycopus Virginicus Whole
Raw Name
LYCOPUS VIRGINICUS WHOLE
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
13
Variant Count
16
Last Verified
February 17, 2026
About Lycopus Virginicus Whole
Lycopus Virginicus Whole is a non-standardized plant allergenic extract used primarily in diagnostic and therapeutic applications for hypersensitivity. It belongs to the class of botanical extracts and is utilized in clinical allergy testing and specific immunotherapy.
Detailed information about Lycopus Virginicus Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Lycopus Virginicus Whole.
Lycopus Virginicus Whole, commonly known as Bugleweed, belongs to a specialized class of pharmacological agents known as Non-Standardized Plant Allergenic Extracts [EPC]. While the plant itself has a long history in traditional botanical medicine, its clinical classification within the modern pharmaceutical framework is primarily as an allergenic source used for the diagnosis and treatment of type I hypersensitivity reactions (allergic reactions). As a non-standardized extract, its potency is not measured in standardized units (such as Bioequivalent Allergenic Units), but rather by the weight of the source material relative to the volume of the extracting solvent (w/v ratio).
In the context of clinical pharmacology, Lycopus Virginicus Whole is part of a broader group of botanical extracts that may be cross-referenced in various databases under multiple Established Pharmacologic Classes (EPC), including Standardized Chemical Allergens and, in rare botanical contexts, agents with potential antiarrhythmic or thyroxine-modulating properties. However, its primary FDA-recognized utility remains within the realm of allergenic extracts. The FDA has regulated these extracts for decades, often under the biologics pathway, ensuring that the source material—the whole plant of Lycopus virginicus—is harvested and processed under Current Good Manufacturing Practices (cGMP) to maintain diagnostic reliability.
Patients should understand that Lycopus Virginicus Whole is not a conventional medication used to treat a disease directly, but rather a tool used by allergists and immunologists to identify specific triggers for allergic rhinitis (hay fever), asthma, or dermatitis. Talk to your healthcare provider to understand how this extract fits into your specific diagnostic or treatment plan.
The mechanism of action for Lycopus Virginicus Whole depends entirely on its application. When used as a diagnostic tool in skin testing, the extract works by introducing minute amounts of plant proteins directly to the skin's mast cells (immune cells that release histamine). If a patient is sensitized to Lycopus virginicus, IgE antibodies on the surface of these mast cells will bind to the extract's proteins, causing the release of histamine and other inflammatory mediators. This results in a localized 'wheal and flare' reaction (a raised bump and redness), which allows the clinician to confirm an allergy.
At a deeper molecular level, when used in immunotherapy (allergy shots), the mechanism involves the gradual induction of immune tolerance. By exposing the patient to increasing doses of the Lycopus Virginicus Whole extract over time, the body shifts its immune response from a Th2-mediated (allergic) pathway to a Th1-mediated or T-regulatory pathway. This leads to the production of IgG4 'blocking antibodies,' which intercept the allergen before it can trigger the IgE-mediated allergic cascade.
Furthermore, independent pharmacological research into the chemical constituents of the Lycopus genus (such as lithospermic acid and other phenolic compounds) suggests that these extracts may interact with the pituitary-thyroid axis. Specifically, they may inhibit the binding of Thyroid Stimulating Hormone (TSH) to its receptors and reduce the peripheral conversion of thyroxine (T4) to the more active triiodothyronine (T3). While these mechanisms are not the primary reason for its use as an allergenic extract, they represent the complex pharmacological profile of the 'whole' plant material. Only your healthcare provider can determine if Lycopus Virginicus Whole is appropriate for your diagnostic needs.
The pharmacokinetics of allergenic extracts like Lycopus Virginicus Whole differ significantly from traditional oral or intravenous drugs. Because these are complex mixtures of proteins, glycoproteins, and polysaccharides, they do not follow a standard ADME (Absorption, Distribution, Metabolism, Excretion) model.
Lycopus Virginicus Whole is primarily indicated for:
> Important: Only your healthcare provider can determine if Lycopus Virginicus Whole is right for your specific condition. The use of this extract must be supervised by a clinician trained in the management of anaphylaxis.
Dosage for Lycopus Virginicus Whole is highly individualized and must be determined by an allergist based on the patient's sensitivity levels. There is no 'standard' dose in the traditional sense.
Lycopus Virginicus Whole is not generally approved for use in infants. In older children, the dosage is determined similarly to adults but with extreme caution. The volume of the extract may be adjusted based on the child's size and the severity of their allergic history. Always consult a pediatric allergist for appropriate dosing in children.
No specific dosage adjustments are provided for patients with kidney disease, as the systemic load of the extract is minimal. However, patients with severe renal failure should be monitored for fluid balance if receiving multiple immunotherapy injections.
No adjustments are typically required for liver impairment, though the patient's overall health and ability to recover from a potential systemic reaction (anaphylaxis) must be considered.
Elderly patients may have reduced skin reactivity, leading to potential false negatives in diagnostic testing. Furthermore, the risk of cardiac complications during a systemic reaction is higher in this population. Lower starting doses in immunotherapy may be prudent.
Lycopus Virginicus Whole is administered exclusively by healthcare professionals in a clinical setting. It is never self-administered for diagnostic purposes. If used for immunotherapy, the following rules apply:
In immunotherapy, consistency is vital. If a dose is missed:
An overdose of Lycopus Virginicus Whole (either by volume or by concentration) can lead to a severe systemic allergic reaction. Signs include:
In the event of an overdose or systemic reaction, epinephrine is the first-line treatment. Emergency medical services must be contacted immediately if the reaction occurs outside a clinical setting.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency without medical guidance. Ensure you inform your doctor of any new medications before your next injection.
Most patients receiving Lycopus Virginicus Whole for skin testing or immunotherapy will experience local reactions. These are generally considered a sign that the medication is interacting with the immune system as intended.
These side effects are more bothersome and may require a dosage adjustment in immunotherapy protocols.
> Warning: Stop taking Lycopus Virginicus Whole and call your doctor immediately if you experience any of these.
When used correctly in immunotherapy, the long-term effect is generally positive (reduced allergy symptoms). However, some risks exist:
While Lycopus Virginicus Whole may not have a specific individual black box warning, all allergenic extracts carry a general class warning from the FDA:
Report any unusual symptoms to your healthcare provider immediately. Even a 'mild' systemic reaction (like a few hives) must be reported before your next dose.
Lycopus Virginicus Whole is a potent biological product that must be handled with extreme care. The primary risk associated with its use is a systemic allergic reaction. Patients must be in their baseline state of health before receiving an injection; for instance, if a patient is experiencing an acute asthma flare or a severe infection, the injection should be postponed. Talk to your healthcare provider about your current health status before every dose.
No specific FDA black box warning exists uniquely for the Lycopus Virginicus species; however, the Allergenic Extract Class Warning applies. This warning emphasizes that Lycopus Virginicus Whole can cause anaphylaxis, which may be fatal. It must be administered in a facility equipped with emergency resuscitative equipment, including oxygen, IV fluids, and epinephrine. Patients must be monitored for a minimum of 30 minutes post-injection.
Lycopus Virginicus Whole does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.
Alcohol should be avoided for several hours before and after receiving an injection of Lycopus Virginicus Whole. Alcohol can increase peripheral vasodilation (widening of blood vessels), which may accelerate the absorption of the allergen or worsen the severity of an allergic reaction.
If a patient experiences a severe systemic reaction, the healthcare provider may decide to discontinue Lycopus Virginicus Whole immunotherapy permanently. There is no 'withdrawal' syndrome associated with stopping allergenic extracts, but the patient's allergy symptoms will likely return to their baseline levels over time.
> Important: Discuss all your medical conditions, especially asthma and thyroid issues, with your healthcare provider before starting Lycopus Virginicus Whole.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or thyroid conditions.
Lycopus Virginicus Whole must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by the healthcare provider include:
Patients allergic to Lycopus Virginicus Whole may show cross-sensitivity to other members of the Lamiaceae (Mint) family. This includes:
If you have had a severe reaction to any of these plants, inform your healthcare provider before undergoing testing with Lycopus Virginicus Whole.
> Important: Your healthcare provider will evaluate your complete medical history, including your current respiratory status and medication list, before prescribing Lycopus Virginicus Whole.
Lycopus Virginicus Whole is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis). Anaphylaxis in the mother can cause a sudden drop in blood pressure, leading to placental hypoperfusion and fetal hypoxia, which can result in fetal brain damage or death.
It is not known whether the allergenic proteins or the pharmacological constituents (like lithospermic acid) of Lycopus Virginicus Whole are excreted in human milk. Because most of the extract consists of large proteins that are digested in the mother's lymphatic system, the risk to the nursing infant is considered low. However, caution should be exercised. Talk to your healthcare provider about the risks and benefits of continuing immunotherapy while breastfeeding.
Safety and effectiveness in children under the age of 5 have not been well established. Children are at a higher risk for systemic reactions because they may not be able to communicate early symptoms of anaphylaxis (like an itchy throat or a sense of doom). For children over 5, the extract is used similarly to adults, but the 'build-up' phase is often managed more conservatively. It is essential to monitor growth and thyroid function if long-term, high-dose exposure is anticipated, although this is rare in standard allergy protocols.
Clinical studies of Lycopus Virginicus Whole did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, elderly patients have a higher prevalence of comorbid conditions like hypertension and coronary artery disease, which increases the risk associated with anaphylaxis. Furthermore, age-related decreases in skin elasticity and mast cell density may result in smaller wheal reactions during diagnostic testing, potentially leading to false negatives.
There is no evidence that renal impairment significantly alters the clearance of allergenic proteins. However, the overall physiological resilience of the patient is a factor in managing potential systemic reactions. No specific dose adjustments are required for GFR (Glomerular Filtration Rate) changes, but close monitoring is advised.
Lycopus Virginicus Whole is not known to be hepatotoxic, nor is its metabolism heavily dependent on the cytochrome P450 system. No adjustments are required based on Child-Pugh classification, but patients with severe liver disease should be treated with the general caution afforded to any patient with significant chronic illness.
> Important: Special populations require individualized medical assessment. Always ensure your allergist is aware of your pregnancy status or any age-related health concerns.
Lycopus Virginicus Whole acts as a complex biological modifier. In the context of Allergenicity, it provides a source of specific epitopes (protein structures) that bind to IgE antibodies on mast cells and basophils. This binding triggers the degranulation of these cells, releasing histamine, leukotrienes, and prostaglandins.
In the context of Thyroid Modulation, the extract contains lithospermic acid and other phenolic acids. These compounds have been shown to:
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous); Negligible (Epicutaneous) |
| Protein Binding | High (to IgE and IgG antibodies) |
| Half-life | Variable (Proteins are degraded within hours/days) |
| Tmax | 15-30 minutes (for local reaction) |
| Metabolism | Local and systemic proteolysis |
| Excretion | Renal (as peptide fragments) |
Lycopus Virginicus Whole is classified as a Non-Standardized Plant Allergenic Extract. It shares this class with other botanical extracts like Ragweed, Timothy Grass, and Oak extracts. It is distinct from 'Standardized' extracts where the potency is calibrated against a national standard.
Common questions about Lycopus Virginicus Whole
Lycopus Virginicus Whole is primarily used as an allergenic extract for the diagnosis and treatment of allergies to the Bugleweed plant. In a clinical setting, an allergist uses this extract to perform skin prick tests to see if a patient has an allergic sensitivity to the plant's proteins. If a sensitivity is confirmed, the extract may be used in 'allergy shots' (immunotherapy) to gradually desensitize the patient's immune system. Historically, the plant has also been used in traditional medicine for mild hyperthyroidism, though this is not its primary FDA-recognized use. Talk to your healthcare provider to see if this extract is necessary for your allergy profile.
The most common side effects are localized to the site of the skin test or injection. These include redness (erythema), itching (pruritus), and the formation of a raised, pale bump called a wheal. Some patients may also experience mild swelling of the arm that can last for a day or two. These reactions are generally normal and indicate that the immune system is responding to the extract. However, if the swelling is larger than the palm of your hand, you should inform your doctor. Always report any systemic symptoms like hives or trouble breathing immediately.
It is strongly recommended to avoid alcohol on the days you receive an injection of Lycopus Virginicus Whole. Alcohol can cause your blood vessels to dilate, which may lead to a faster-than-intended absorption of the allergen into your bloodstream. This increased absorption rate can raise the risk of a systemic allergic reaction or anaphylaxis. Additionally, alcohol can mask early symptoms of a reaction, such as dizziness or flushing. To ensure your safety during immunotherapy, stay hydrated with water and avoid alcoholic beverages for at least 24 hours around your appointment.
Lycopus Virginicus Whole is generally not started during pregnancy because of the risk of anaphylaxis, which can be dangerous for both the mother and the baby. If a mother has a severe allergic reaction, it can cause a drop in blood pressure that reduces the oxygen supply to the fetus. However, if a woman is already on a stable maintenance dose of immunotherapy before becoming pregnant, her doctor may choose to continue the treatment. The decision is based on a careful risk-benefit analysis. Always inform your allergist immediately if you become pregnant or are planning to become pregnant.
For diagnostic purposes, Lycopus Virginicus Whole works very quickly, with skin test results appearing in just 15 to 20 minutes. However, when used for immunotherapy (allergy shots) to treat an allergy, it takes much longer to see a benefit. Most patients begin to notice a reduction in their allergy symptoms after 3 to 6 months of the 'build-up' phase. The full benefits are typically realized after 12 to 18 months of consistent maintenance injections. Most doctors recommend continuing the treatment for 3 to 5 years to ensure long-lasting immune tolerance.
Yes, you can stop taking Lycopus Virginicus Whole injections suddenly without experiencing a 'withdrawal' syndrome like you might with some other medications. However, stopping immunotherapy prematurely will likely result in the return of your original allergy symptoms over time. If you stop for several weeks and then decide to restart, you cannot simply resume at your previous dose; your doctor will need to lower the dose and slowly build it back up to avoid a reaction. Always discuss your reasons for wanting to stop with your healthcare provider first.
If you miss a dose of Lycopus Virginicus Whole during your immunotherapy schedule, contact your allergist's office to reschedule as soon as possible. The safety of your next dose depends on how much time has passed since your last injection. If it has only been a few extra days, you may be able to receive your regular dose. If several weeks have passed, your doctor will likely need to reduce the concentration of the extract to prevent a systemic reaction. Never try to 'double up' on doses to make up for a missed one.
There is no clinical evidence that Lycopus Virginicus Whole causes weight gain when used as an allergenic extract for skin testing or immunotherapy. However, because the Lycopus plant has pharmacological effects that can slow down the thyroid gland (mild anti-thyroid effect), extremely high or frequent systemic exposure could theoretically lead to symptoms of an underactive thyroid (hypothyroidism), one of which is weight gain. This is not a typical side effect of standard allergy treatments. If you notice unexplained weight gain while on this treatment, talk to your healthcare provider about checking your thyroid levels.
Lycopus Virginicus Whole can interact with several types of medications, some of which are very serious. You must not take non-selective beta-blockers (like propranolol) while receiving these injections, as they can make a severe allergic reaction impossible to treat. Other medications like ACE inhibitors, MAOIs, and even thyroid hormones (like levothyroxine) can interact with the extract or the way your body responds to it. Antihistamines must also be stopped before skin testing to ensure accurate results. Always provide your doctor with a complete list of all your current medications.
Lycopus Virginicus Whole is a biological product rather than a simple chemical drug, so the term 'generic' is not used in the same way. Instead, there are multiple manufacturers who produce their own versions of Lycopus Virginicus extracts. While these extracts are all derived from the same plant, they are 'non-standardized,' meaning the exact protein concentration may vary between different brands. It is generally recommended to stay with the same manufacturer's extract throughout your course of immunotherapy to ensure the dosage remains consistent and safe. Talk to your pharmacist or allergist about the specific brand they use.